Tissue microarray-based expression profiling demonstrated that hepsin expression was upregulated in prostate cancer specimens, but low or no hepsin expression was detected in normal prostate and BPH specimens [7,8,9,10,11]. The gene discussed is HPN; the disease is benign prostatic hyperplasia.